TEL AVIV, Israel, Oct. 06, 2020 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR) (“Company”), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease (CAD), today announced the appointment of Patrick Jamnik as vice president, business development and strategic initiatives. In this newly created position, Mr. Jamnik will oversee the Company’s business development activities and play a key role in advancing its short and long-term strategic goals, with much of his focus being the U.S. market.
“At different times throughout my career, I have been fortunate to see the powerful impact created when pioneering technology encounters genuine unmet clinical needs. CGuard™ EPS presents the opportunity to create such an impact on the advancement of carotid artery stenting,” said Mr. Jamnik. “I am thrilled to be joining InspireMD at such an important and exciting time.”
Mr. Jamnik brings with him more
…
Read More